晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

休市中 01-30 16:08:04

12.080

-0.430

-3.44%

最高12.390	最低11.710	成交量6,815万
今开12.330	昨收12.510	日振幅5.44%
总市值519.80亿	流通市值519.80亿	总股本43.03亿
成交额8.17亿	换手率1.58%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":12.08,"timestamp":1769760484005,"preClose":12.51,"halted":0,"volume":68145003,"delay":0,"changeRate":-0.03437250199840126,"floatShares":4303000000,"shares":4303000000,"eps":-0.786038,"marketStatus":"休市中","change":-0.43,"latestTime":"01-30 16:08:04","open":12.33,"high":12.39,"low":11.71,"amount":816822416,"amplitude":0.054357,"askPrice":12.08,"askSize":109000,"bidPrice":12.07,"bidSize":7000,"shortable":3,"etf":0,"ttmEps":-0.05,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":7,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":12.51,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":0.880188,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"2607048040","title":"安科生物：公司正积极与英硅智能、晶泰科技、元构生物等公司对接，推动AI在小分子、多肽、大分子蛋白质药物的靶点筛选，分子发现、结构优化等环节的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2607048040","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607048040?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:53","pubTimestamp":1769777603,"startTime":"0","endTime":"0","summary":"证券之星消息，安科生物(300009)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司有没有利用AI的在研药物，或者已经进入临床的药物。如果有，请问有那些药物。安科生物回复：您好，公司正积极与英硅智能、晶泰科技、元构生物等公司对接，推动AI在小分子、多肽、大分子蛋白质药物的靶点筛选，分子发现、结构优化等环节的应用。谢谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000043737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","300009","BK0239","BK1141","BK1617","BK0042","BK0070","02228"],"gpt_icon":0},{"id":"2607438052","title":"每日卖空追踪 | 晶泰控股 01月29日卖空量成交148万股，卖空比例为2.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607438052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607438052?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675430,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间01月29日，涨0.64%，卖空量成交148万股，较上一交易日减少47.67%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164016a463eaf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164016a463eaf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141","BK1617"],"gpt_icon":0},{"id":"2606797815","title":"晶泰控股(02228)完成发行28.66亿港元于2027年到期的零息可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2606797815","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606797815?lang=zh_cn&edition=full","pubTime":"2026-01-28 18:26","pubTimestamp":1769596008,"startTime":"0","endTime":"0","summary":"晶泰控股(02228)发布公告，认购协议项下所有关于发行债券的先决条件均已达成，而本金总额28.66亿港元的债券已于2026年1月28日完成发行。","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_50.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_50.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"晶泰控股(02228)完成发行28.66亿港元于2027年到期的零息可转换债券","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4581","02228","BK4585","BK1617","BK1141","BK4588"],"gpt_icon":0},{"id":"2606079787","title":"纽曼思(02530)购入总共200万股晶泰科技股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2606079787","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606079787?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:06","pubTimestamp":1769522795,"startTime":"0","endTime":"0","summary":"智通财经APP讯，纽曼思(02530)发布公告，于2026年1月27日，本集团于公开市场以总代价约 2570万港元(包括印花税及相关开支)购入总共200万股晶泰科技股份。所购入的晶泰科技200万股股份的平均购买价约为每股12.84港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1207","02530","BK1141","BK1617"],"gpt_icon":0},{"id":"2605847367","title":"每日卖空追踪 | 晶泰控股 01月23日卖空量成交341.1万股，卖空比例为3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605847367","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605847367?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157028,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间01月23日，涨4.5%，卖空量成交341.1万股，较上一交易日增加30.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163844a44d9ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163844a44d9ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2605473986","title":"晶泰控股01月23日主力净流入4321.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2605473986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605473986?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156139,"startTime":"0","endTime":"0","summary":"01月23日, 晶泰控股股价涨4.50%，报收13.48元，成交金额11.8亿元，换手率2.05%，振幅4.57%，量比1.32。晶泰控股今日主力资金净流入4321.4万元，上一交易日主力净流出683.6万元。该股近5个交易日上涨6.49%，主力资金累计净流入8714.8万元；近20日主力资金累计净流入6.3亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161935a6a434ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161935a6a434ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2605544053","title":"港股异动 | 晶泰科技(02228)盘中涨近5% 赋能莱芒生物取得细胞疗法重大成果 多个实体瘤领域IIT临床将启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2605544053","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605544053?lang=zh_cn&edition=full","pubTime":"2026-01-23 10:52","pubTimestamp":1769136721,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰科技盘中涨近5%，截至发稿，涨3.88%，报13.4港元，成交5.96亿港元。消息面上，近日，晶泰科技孵化企业莱芒生物在第44届摩根大通医疗健康年会发表演讲，并向全球投资者展示了其极低剂量CAR-T疗法的研究者发起临床最新成果。同时，这一疗法已助数十位复发难治性白血病/淋巴瘤患者达到CR，并有多个实体瘤领域IIT临床正在开展或即将启动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1617","02228","BK1610"],"gpt_icon":1},{"id":"2605442845","title":"晶泰科技(02228)赋能莱芒生物取得细胞疗法重大成果，以1‰剂量CAR-T实现多位系统性红斑狼疮完全缓解出院","url":"https://stock-news.laohu8.com/highlight/detail?id=2605442845","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605442845?lang=zh_cn&edition=full","pubTime":"2026-01-23 09:54","pubTimestamp":1769133255,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，晶泰科技孵化企业莱芒生物在第 44 届摩根大通医疗健康年会发表演讲，并向全球投资者展示了其极低剂量 CAR-T 疗法的研究者发起临床最新成果。血液瘤与自身免疫疾病临床双重突破在晶泰科技的助力下，莱芒生物开发的代谢增强型 CD19 CAR-T疗法，在自免性疾病和血液瘤领域展现出突破性治疗潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4230","02228","BK1617","BK4022","BK1141","CAR"],"gpt_icon":0},{"id":"2605817260","title":"每日卖空追踪 | 晶泰控股 01月21日卖空量成交121万股，卖空比例为2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605817260","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605817260?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984231,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间01月21日，股价较前一交易日持平，卖空量成交121万股，较上一交易日减少82.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165544a69b843d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165544a69b843d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1617","02228"],"gpt_icon":0},{"id":"2605217497","title":"晶泰控股01月21日主力净流入1451.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2605217497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605217497?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:16","pubTimestamp":1768983362,"startTime":"0","endTime":"0","summary":"01月21日，晶泰控股股价收平报12.93元，成交金额5.9亿元，换手率1.06%，振幅3.09%，量比0.30。晶泰控股今日主力资金净流入1451.0万元，上一交易日主力净流出4183.8万元。该股近5个交易日下跌7.44%，主力资金累计净流出2.7亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入6.4亿元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121163537a444c10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121163537a444c10c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"gpt_icon":0},{"id":"2604538193","title":"晶泰控股01月20日主力净流出4183.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2604538193","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604538193?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:15","pubTimestamp":1768896946,"startTime":"0","endTime":"0","summary":"01月20日, 晶泰控股股价跌0.77%，报收12.93元，成交金额8.7亿元，换手率1.59%，振幅4.53%，量比0.37。晶泰控股今日主力资金净流出4183.8万元，上一交易日主力净流入7810.0万元。该股近5个交易日下跌3.49%，主力资金累计净流出1.4亿元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入6.2亿元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162809a4403161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120162809a4403161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":1},{"id":"2604181673","title":"每日卖空追踪 | 晶泰控股 01月19日卖空量成交452.1万股，卖空比例为5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604181673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604181673?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811428,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间01月19日，涨3.09%，卖空量成交452.1万股，较上一交易日减少26.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。港股数据实时性强，适合短线跟踪；美股因T+2延迟，更适用中长期分析。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164057a43c25cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164057a43c25cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"gpt_icon":0},{"id":"2604920167","title":"晶泰控股获摩根大通增持2996.4263万股 每股作价12.5925港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604920167","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604920167?lang=zh_cn&edition=full","pubTime":"2026-01-18 16:48","pubTimestamp":1768726080,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月12日，摩根大通增持晶泰控股（02228）2996.4263万股，每股作价12.5925港元，总金额约为3.77亿港元。增持后最新持股数目约为4.01亿股，最新持股比例为9.31%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-18/doc-inhhthyt3599899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0323591593.USD","LU0820561909.HKD","IE0034235303.USD","LU0964807845.USD","LU2357305700.SGD","IE00B1XK9C88.USD","LU0868494708.USD","LU1894683264.USD","LU0942090050.USD","LU2211815571.USD","LU0256863811.USD","IE0034235295.USD","LU0234572021.USD","LU1496350171.SGD","LU0345769631.USD","LU2552382215.SGD","LU2462157665.USD","LU0211326755.USD","LU2552382132.HKD","LU0882574139.USD","LU0265550359.USD","LU1363072403.SGD","BK4550","LU0267386448.USD","LU1548497426.USD","LU2756315318.SGD","LU0106261372.USD","IE00BFXG1179.USD","LU1162221912.USD","LU2023250330.USD","IE00BDRTCR15.USD","IE00BBT3K403.USD","LU1244550577.SGD","LU1670628061.USD","LU1917777945.USD","LU2430703178.SGD","IE000M9KFDE8.USD","LU2242649171.HKD","IE00BWXC8680.SGD","LU2592432038.USD","LU0976567544.SGD","02228","LU0310799852.SGD","LU2237443382.USD","LU0211331839.USD","LU1551013342.USD","LU2237443978.SGD","LU0345770993.USD","LU0640476718.USD","LU0683600562.USD"],"gpt_icon":0},{"id":"2603864995","title":"摩根大通增持晶泰控股(02228)2996.4263万股 每股作价12.5925港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603864995","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603864995?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:26","pubTimestamp":1768566390,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月12日，摩根大通增持晶泰控股(02228)2996.4263万股，每股作价12.5925港元，总金额约为3.77亿港元。增持后最新持股数目约为4.01亿股，最新持股比例为9.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443465.HKD","LU0868494708.USD","LU1366192091.USD","LU1244550577.SGD","LU2462157665.USD","SG9999002224.SGD","LU2023250843.SGD","LU2430703095.HKD","LU0234572021.USD","LU1116320737.USD","LU0943347566.SGD","SG9999002232.USD","BK4533","LU0149725797.USD","LU2381873111.SGD","LU2242649171.HKD","IE00BJTD4V19.USD","LU1720051108.HKD","LU0211326839.USD","LU0211328371.USD","LU2236285917.USD","LU0211326755.USD","LU0787776722.HKD","02228","LU1668664300.SGD","LU1670627923.USD","LU0868494617.USD","BK4207","LU0345769631.USD","LU0170899867.USD","LU0215105999.USD","LU0345770993.USD","LU1162221912.USD","BK4581","LU0323591593.USD","BK4588","BK4504","IE000M9KFDE8.USD","LU1280957306.USD","LU0964807845.USD","LU1244550221.USD","LU0320765489.SGD","LU0345769128.USD","LU0211331839.USD","LU0820561818.USD","LU0882574139.USD","LU1894683264.USD","LU0267386448.USD","IE00BDRTCR15.USD","IE00BWXC8680.SGD"],"gpt_icon":0},{"id":"2603704356","title":"每日卖空追踪 | 晶泰控股 01月15日卖空量成交785.9万股，卖空比例为2.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603704356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603704356?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465828,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间01月15日，跌10.74%，卖空量成交785.9万股，较上一交易日减少57.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164143a4c6d466&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164143a4c6d466&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1617","BK1141"],"gpt_icon":0},{"id":"2603676217","title":"中邮证券：AI已成为新药物发现“加速引擎” 建议关注AI4S、AI+制药赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2603676217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603676217?lang=zh_cn&edition=full","pubTime":"2026-01-15 14:40","pubTimestamp":1768459225,"startTime":"0","endTime":"0","summary":"AI已成为新药物发现的“加速引擎”，通过预测结合能、溶解性、毒性等关键参数，AI可以在虚拟空间中高速筛选、优化甚至从头设计出具有潜力的候选分子或新材料，有望缩短药物发现时间。原理层面，在规则清晰的分子世界，AI已成为新药物发现的“加速引擎”中邮证券认为，AI模型，特别是深度学习与生成式模型，能够高效学习海量的分子结构、化学键、物化性质与生物活性之间的复杂映射关系。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01276","LU0359201612.USD","LU0359202008.SGD","01477","LU0708995583.HKD","02228","LU0320764599.SGD","LU0359201885.HKD","02359","BK1576","LU2125910500.SGD","LU2045819591.USD","161027","LU0052750758.USD","BK1583","LU2242644610.SGD","BK1617","LU1046422090.SGD","LU2543165471.USD","LU1023057109.AUD","BK1191","BK1141"],"gpt_icon":1},{"id":"1159288621","title":"异动解读 | AI医疗概念股全线回调，晶泰控股盘中大跌11.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159288621","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159288621?lang=zh_cn&edition=full","pubTime":"2026-01-15 13:44","pubTimestamp":1768455871,"startTime":"0","endTime":"0","summary":"晶泰控股(02228)今日盘中大幅下跌11.52%，成为市场关注的焦点。消息面上，AI医疗概念股今日普遍走弱，晶泰控股领跌板块，跌幅一度超过10%。同期，阿里健康(00241)、方舟健客(06086)等同类股票也出现显著下跌，显示此次下跌为行业整体回调。近期，美国FDA加速推进替代动物实验的相关政策，AI建模、类器官等技术成为焦点，这可能对传统医疗研发企业造成压力，但具体到今日下跌，主要驱动因素仍是板块整体资金流出。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2603659416","title":"中邮证券：AI医疗行业加速发展 在制药、辅助诊断、医疗服务等领域步入成熟阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2603659416","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603659416?lang=zh_cn&edition=full","pubTime":"2026-01-14 11:41","pubTimestamp":1768362075,"startTime":"0","endTime":"0","summary":"AI在制药、医疗影像、辅助诊疗等领域正步入成熟应用，推动产业链价值提升，医疗AI三类证审批加速进一步助力行业持续扩张。海外AI医疗公司业绩高增预期及全球业内头部公司持续加大投入，有望映射国内同类公司未来业绩预期。AI在制药、辅助诊断、医疗服务等领域步入成熟阶段在制药领域，凭借AI技术平台强大的数据分析和模型预测能力，相关公司在分子设计和药物筛选方面能够大幅提升药物的研发效率和成功率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114114423a4c15857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"19a45d98d676f675f3dd1dad1f11fa69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114114423a4c15857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1617","02251","02506","02228","BK1191","BK1141","01477"],"gpt_icon":1},{"id":"2603574366","title":"港股异动 | 晶泰控股(02228)再涨超4% ReviR创新药RTX-117获中美临床批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2603574366","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603574366?lang=zh_cn&edition=full","pubTime":"2026-01-14 10:01","pubTimestamp":1768356115,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股再涨超4%，月内累计涨幅接近50%。ReviR将继续完成RTX-117的后续临床开发，晶泰科技有权参与该管线的销售分成及后续授权收益分成。该行认为RTX-117临床获批标志其技术平台进入价值兑现期，随着合作管线梯队持续扩容，业绩弹性与估值重塑空间广阔。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1929549753.HKD","BK4566","BK4585","IE00B775SV38.USD","LU1430594728.SGD","RTX","LU0787776722.HKD","IE00B3S45H60.SGD","LU0640476718.USD","LU1280957306.USD","LU0683600562.USD","BK4187","BK4550","02228","BK1574","06978","LU1162221912.USD","BK1141","LU1585245621.USD","BK1617","159992","LU0320765646.SGD","BK4588","BK1161","LU1366192091.USD"],"gpt_icon":0},{"id":"2603573916","title":"管线成果超预期 获数千万港币里程碑付款！晶泰科技(02228)赋能AI+RNA新药RTX-117获中美临床批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573916","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573916?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:23","pubTimestamp":1768353831,"startTime":"0","endTime":"0","summary":"ReviR 将继续完成 RTX-117 的后续临床开发，晶泰科技有权参与该管线的销售分成及后续授权收益分成。RTX-117 为晶泰科技与 ReviR 深度合作的一系列研发管线中首个里程碑成果，其临床前数据及临床获批速度均超出双方预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392536.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RNA","IE00B3S45H60.SGD","LU1430594728.SGD","IE00B775SV38.USD","LU1162221912.USD","RTX","02228","BK4585","BK4588","LU1929549753.HKD","BK4505","LU1366192091.USD","LU0787776722.HKD","IE0009354923.USD","LU1585245621.USD","BK1141","LU1280957306.USD","LU0640476718.USD","BK1617","LU0683600562.USD","BK4566","BK4139","BK4550","LU0320765646.SGD","BK4187"],"gpt_icon":1}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.1039},{"period":"1month","weight":0.277},{"period":"3month","weight":0.0634},{"period":"6month","weight":1.1193},{"period":"1year","weight":1.3231},{"period":"ytd","weight":0.277}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}